Pharmacologic IRE1/XBP1s activation confers targeted ER proteostasis reprogramming.

MLA

Grandjean, Julia M. D., et al. “Pharmacologic IRE1/XBP1s Activation Confers Targeted ER Proteostasis Reprogramming.” Nature Chemical Biology, vol. 16, no. 10, Oct. 2020, pp. 1052–61. EBSCOhost, https://doi.org/10.1038/s41589-020-0584-z.

APA

Grandjean, J. M. D., Madhavan, A., Cech, L., Seguinot, B. O., Paxman, R. J., Smith, E., Scampavia, L., Powers, E. T., Cooley, C. B., Plate, L., Spicer, T. P., Kelly, J. W., & Wiseman, R. L. (2020). Pharmacologic IRE1/XBP1s activation confers targeted ER proteostasis reprogramming. Nature Chemical Biology, 16(10), 1052–1061. https://doi.org/10.1038/s41589-020-0584-z

Chicago

Grandjean, Julia M D, Aparajita Madhavan, Lauren Cech, Bryan O Seguinot, Ryan J Paxman, Emery Smith, Louis Scampavia, et al. 2020. “Pharmacologic IRE1/XBP1s Activation Confers Targeted ER Proteostasis Reprogramming.” Nature Chemical Biology 16 (10): 1052–61. doi:10.1038/s41589-020-0584-z.